RECURRENT GANGLIONEUROBLASTOMA

Clinical trials for RECURRENT GANGLIONEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GANGLIONEUROBLASTOMA trials appear

Sign up with your email to follow new studies for RECURRENT GANGLIONEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for kids battling tough neuroblastoma

Disease control Not yet recruiting

This study is testing whether adding a new drug called iberdomide to a standard combination of chemotherapy and immunotherapy is safe and more effective for children and young adults with neuroblastoma that has returned, is not responding, or is getting worse after prior treatmen…

Matched conditions: RECURRENT GANGLIONEUROBLASTOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

RECURRENT GANGLIONEUROBLASTOMA

Get alerted when new RECURRENT GANGLIONEUROBLASTOMA trials appear

New hope for kids battling tough neuroblastoma